Page breadcrumb nav

VAERS Report 2115806

Case Report Section

Vaer Report Details

Age: 59 years old

Gender: Female

State: Massachusetts

Patient Died?
No
Vaccine information

Name: VACCINE NOT SPECIFIED (NO BRAND NAME)

Type: Unknown vaccine type

Manufacturer: UNKNOWN

Lot: unknown


Date report was received
2022-02-16
Date form completed
Date Vaccinated
2021-04-13
Date of Onset
0
Number of days (onset date – vaccination date)
0
Adverse Event Description

had a drug interaction with pfizer covid-19; told that the drug interaction pfizer covid-19 affected her right hip.; she had debility with ambulation for 5 days; brain fog; pain; she was only capable of ambulating from bed to bathroom; this is a spontaneous report received from contactable reporter(s) (consumer or other non hcp). the reporter is the patient. other case identifier(s): nvsc2020us100435_ns. a 59 year-old female patient received bnt162b2 (bnt162b2), administration date 13apr2021 (batch/lot number: unknown) at the age of 59 years as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: bnt162b2 (first dose), administration date: 23mar2021, when the patient was 59 years old, for covid-19 immunization, reaction(s): "she had debility with ambulation"; bnt162b2 (first dose), administration date: 23mar2021, for covid-19 immunization, reaction(s): "pain", "brain fog". the following information was reported: asthenia (non-serious) with onset 2021, outcome "unknown", described as "she had debility with ambulation for 5 days"; feeling abnormal (non-serious) with onset 2021, outcome "unknown", described as "brain fog"; pain (non-serious) with onset 2021, outcome "unknown", described as "pain"; dyskinesia (non-serious) with onset 2021, outcome "unknown", described as "she was only capable of ambulating from bed to bathroom"; drug interaction (non-serious), outcome "unknown", described as "had a drug interaction with pfizer covid-19"; musculoskeletal discomfort (non-serious), outcome "unknown", described as "told that the drug interaction pfizer covid-19 affected her right hip.". relevant laboratory tests and procedures are available in the appropriate section. additional information: patient reported received 2 dose of pfizer vaccine, 1st dose on 23mar2021 and 2nd dose on 13apr2021, patient stated after first dose she had debility with ambulation, brain fog and pain for 2 days. with receiving 2nd dose, patient reported continuous brain fog, pain and of debility with ambulation for 5 days. she was only capable of ambulating from bed to bathroom. she had a drug interaction with pfizer covid-19, 2nd injection, which was admin 13apr2021. several mris and blood work was collected, and pt. was told that the drug interaction pfizer covid-19 affected her right hip. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Lab Data
test date: 2021; test name: blood work; result unstructured data: test result:unknown results; test date: 2021; test name: mri; result unstructured data: test result:unknown results
List of symptoms
feeling abnormal drug interaction dyskinesia pain asthenia musculoskeletal discomfort magnetic resonance imaging blood test
Patient Died?
No
Date Died
NA
Birth defect
false
Vaccine Administered By:
Unknown
Vaccine Purchased By:
Unknown
Patient visit ER?
No
Patient Hospitalized?
No
Stay in hospital
No
Days in hospital
Unspecified
Permanent disability?
No
Allergies:
na
Current Illness
na